Colon cancer will be diagnosed in approximately 150,000 Americans in 2024. It’s the fourth most diagnosed cancer in the United States and one of the leading causes of cancer deaths, according to ...

As scientists question the rise in early colon cancer cases, a new study is offering some potential answers. Colored scanning electron micrograph (SEM) of a macrophage white blood cell (center ...

Screening rates for colonoscopy or stool testing more than doubled, rising from just over 37% in 2000 to nearly 80% in 2019 across all racial and ethnic groups, researchers report. Colon cancer ...

Colon cancer is one of the most common cancers in the United States and cases among younger adults are rising. Early detection is critical, as symptoms may not appear until the cancer has progressed.

The five-year survival rate for stage 3A is 83.4%, but it plummets to 64.1% for stage 3B, according to the American Joint Committee on Cancer. Bell remembers the shock of hearing the diagnosis.

Colorectal cancer stands as the third leading cause of cancer-related deaths in US men and the fourth leading cause in US women, according to the American Cancer Society. This year, over 150,000 ...

Early colon cancer symptoms can be mild The most common colon cancer symptoms in people under 50 include abdominal pain, altered bowel movements, constipation, bloating, and diarrhea.

University of Texas at El Paso. "Portable, blood-based device detects colon cancer." ScienceDaily. ScienceDaily, 13 March 2025. <www.sciencedaily.com / releases / 2025 / 03 / 250313152001.htm>.

Colorectal cancer is on the rise among younger people, according to a community announcement. In the next decade, 25% of rectal cancers and 10% to 12% of colon cancers are expected to be diagnosed ...

After a colon cancer diagnosis, there can still be healthy years ahead, experts said. Regular physical activity may be an important part of that, research suggests.

Tumor deposits negatively impact colon cancer survival, but the AJCC tumor, lymph node, and metastasis (TNM) staging system only considers these deposits in the absence of positive lymph nodes.

Three-year results from the ALASCCA trial (NCT02647099), presented at the 2025 ASCO Gastrointestinal Cancer Symposium, showed that aspirin use in patients with PIK3CA-mutated colorectal cancer reduced ...